Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Researchers conducted a study to assess how pre-existing mental disorders are associated with a SARS-CoV-2 infection and how different clusters of mental disorders affect COVID-19 clinical outcomes.

27 Oct 2021

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Researchers from the University of Veterinary Medicine Hannover have been investigating the spread of the disease in domestic cats in Europe.

27 Oct 2021

Model for the simulation of SARS-CoV-2 community transmission in congregate facilities

Researchers have examined the factors that caused the most significant outbreaks in congregate settings such as care homes and prisons.

27 Oct 2021

Study shows sustained deterioration of mental health in UK across COVID pandemic

To date, it is not clear how the COVID-19 pandemic and implementation of various preventive strategies impacted mental health or which group of people were most affected by them. To address these issues, scientists have conducted coordinated analyses that included eleven UK longitudinal population studies, comprising data from before and throughout the pandemic.

27 Oct 2021

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

A recent study by researchers from the Netherlands highlights that the introduction of vaccination programs against coronavirus disease 2019 (COVID-19) to adolescents and children may reduce infection rates and severe disease outcomes – both in these age groups and in the population as a whole. The paper is currently available on medRxiv* preprint server while it undergoes peer review.

26 Oct 2021

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

Researchers from the University of Oxford have recently analyzed pregnancies that have occurred during four ChAdOx1 nCoV-19 clinical trials.

26 Oct 2021

SARS-CoV-2 detection with natural spring water gargle instead of nasopharyngeal swabs

A team of researchers validated the use of spring water gargle as an alternative to ONPS for the detection of SARS-CoV-2.

26 Oct 2021

Brain fog in long COVID

A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.

26 Oct 2021

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

A new study discusses the durability of the immune response following natural infection or vaccination.

26 Oct 2021

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Researchers from Oregon State University have developed a system to assess the ability of SARS-CoV-2 to bind to ACE2 orthologs.

26 Oct 2021

Attitudes towards COVID-19 vaccination amongst essential workers

A new study has addressed these gaps in knowledge regarding the uptake of COVID-19 vaccines among essential workers.

26 Oct 2021

Identification of long COVID patients using big data

A new preprint exploits big data to come up with some answers as to the incidence, treatment, and impact on healthcare systems of long covid.

26 Oct 2021

Post COVID-19 affects children as well as adults

A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.

26 Oct 2021

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children.

26 Oct 2021

Water and surface surveillance can detect 93% of school-based COVID-19 cases

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.

25 Oct 2021

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.

25 Oct 2021

SARS-CoV-2 delta variant generates infections more quickly than previous strains

Researchers in the UK have conducted a study suggesting that the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – is transmitted more quickly than previously circulating variants.

25 Oct 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Model for the simulation of SARS-CoV-2 community transmission in congregate facilities

Study shows sustained deterioration of mental health in UK across COVID pandemic

Postpartum women's experience of social restrictions during COVID-19

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

AstraZeneca ChAdOx1 nCoV-19 vaccine does not affect fertility and birth rate outcomes, study says

SARS-CoV-2 detection with natural spring water gargle instead of nasopharyngeal swabs

Brain fog in long COVID

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Attitudes towards COVID-19 vaccination amongst essential workers

Identification of long COVID patients using big data

Post COVID-19 affects children as well as adults

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

Water and surface surveillance can detect 93% of school-based COVID-19 cases

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

SARS-CoV-2 delta variant generates infections more quickly than previous strains

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in